155
Views
15
CrossRef citations to date
0
Altmetric
Original Articles

Dose-Dependent Suppression of Tea Catechins with a Galloyl Moiety on Postprandial Hypertriglyceridemia in Rats

, , , , &
Pages 1288-1291 | Received 17 Jan 2005, Accepted 12 Apr 2005, Published online: 22 May 2014

  • 1) Hokanson, J. E., and Austin, M. A., Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies. J. Cardiovasc. Risk, 3, 213–219 (1996).
  • 2) Groot, P. H., van Stiphout, W. A., Krauss, X. H., Jansen, H., van Tol, A., van Ramshorst, E., Chin-On, S., Hofman, A., Cresswell, S. R., and Havekes, L., Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler. Thromb., 11, 653–662 (1991).
  • 3) Patsch, J. R., Miesenbock, G., Hopferwieser, T., Muhlberger, V., Knapp, E., Dunn, J. K., Gotto Jr., A. M., and Patsch, W., Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler. Thromb., 12, 1336–1345 (1992).
  • 4) Yang, C. S., and Landau, J. M., Effects of tea consumption on nutrition and health. J. Nutr., 130, 2409–2412 (2000).
  • 5) Chen, Z. Y., Zhu, Q. Y., Tsang, D., and Huang, Y., Degradation of green tea catechins in tea drinks. J. Agric. Food Chem., 49, 477–482 (2001).
  • 6) Seto, R., Nakamura, H., Nanjo, F., and Hara, Y., Preparation of epimers of tea catechins by heat treatment. Biosci. Biotechnol. Biochem., 61, 1434–1439 (1997).
  • 7) Ikeda, I., Tsuda, K., Suzuki, Y., Kobayashi, M., Unno, T., Tomoyori, H., Goto, H., Kawata, Y., Imaizumi, K., Nozawa, A., and Kakuda, T., Tea catechins with a galloyl moiety suppress postprandial hypertriacylglycerolemia by delaying lymphatic transport of dietary fat in rats. J. Nutr., 135, 155–159 (2005).
  • 8) Kido, Y., Hiramoto, S., Murao, M., Horio, Y., Miyazaki, T., Kodama, T., and Nakabou, Y., ε-Polylysine inhibits pancreatic lipase activity and suppresses postprandial hypertriacylglyceridemia in rats. J. Nutr., 133, 1887–1891 (2003).
  • 9) Wolever, T. M., Jenkins, D. J., Jenkins, A. L., and Josse, R. G., The glycemic index: methodology and clinical implications. Am. J. Clin. Nutr., 54, 846–854 (1991).
  • 10) Unno, T., Sugimoto, A., and Kakuda, T., Scavenging effect of tea catechins and their epimers on superoxide anion radicals generated by a hypoxanthine and xanthine oxidase system. J. Sci. Food Agric., 80, 601–606 (2000).
  • 11) Unno, T., Yayabe, F., Hayakawa, T., and Tsuge, H., Electron spin resonance spectroscopic evaluation of scavenging activity of tea catechins on superoxide radicals generated by a phenazine methosulfate and NADH system. Food Chem., 76, 259–265 (2002).
  • 12) Yoshino, K., Hara, Y., Sano, M., and Tomita, I., Antioxidative effects of black tea theaflavins and thearubigin on lipid peroxidation of rat liver homogenates induced by tert-butyl hydroperoxide. Biol. Pharm. Bull., 17, 146–149 (1994).
  • 13) Fujiki, H., Suganuma, M., Okabe, S., Sueoka, N., Komori, A., Sueoka, E., Kozu, T., Tada, Y., Suga, K., Imai, K., and Nakachi, K., Cancer inhibition by green tea. Mutat. Res., 402, 307–310 (1998).
  • 14) Valsa, A. K., Sudheesh, S., and Vijayalakshmi, N. R., Effect of catechin on carbohydrate metabolism. Indian J. Biochem. Biophys., 34, 406–408 (1997).
  • 15) Henry, J. P., and Stephens-Larson, P., Reduction of chronic psychosocial hypertension in mice by decaffeinated tea. Hypertension, 6, 437–444 (1984).
  • 16) Ikeda, I., Kobayashi, M., Hamada, T., Tsuda, K., Goto, H., Imaizumi, K., Nozawa, A., Sugimoto, A., and Kakuda, T., Heat-epimerized tea catechins rich in gallocatechin gallate and catechin gallate are more effective to inhibit cholesterol absorption than tea catechins rich in epigallocatechin gallate and epicatechin gallate. J. Agric. Food Chem., 51, 7303–7307 (2003).
  • 17) Okabe, S., Suganuma, M., Hayashi, M., Sueoka, E., Komori, A., and Fujiki, H., Mechanisms of growth inhibition of human lung cancer cell line, PC-9, by tea polyphenols. Jpn. J. Cancer Res., 88, 639–643 (1997).
  • 18) Tezuka, M., Suzuki, H., Suzuki, Y., Hara, Y., and Okada, S., Inactivation effect of tea leaf catechins on human type-A influenza virus. Jpn. J. Toxicol. Environ. Health (in Japanese), 43, 311–315 (1997).
  • 19) Ishikawa, T., Suzukawa, M., Ito, T., Yoshida, H., Ayaori, M., Nishiwaki, M., Yonemura, A., Hara, Y., and Nakamura, H., Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am. J. Clin. Nutr., 66, 261–266 (1997).
  • 20) Miura, S., Watanabe, J., Tomita, T., Sano, M., and Tomita, I., The inhibitory effects of tea polyphenols (flavan-3-ol derivatives) on Cu2+ mediated oxidative modification of low density lipoprotein. Biol. Pharm. Bull., 17, 1567–1572 (1994).
  • 21) Hara, Y., and Watanabe, M., Antibacterial activity of tea polyphenols against Clostridium botulinum. Nippon Shokuhin Kogyo Gakkaishi (in Japanese), 36, 951–955 (1989).
  • 22) Kajiya, K., Kumazawa, S., and Nakayama, T., Steric effects on interaction of tea catechins with lipid bilayers. Biosci. Biotechnol. Biochem., 65, 2638–2643 (2001).
  • 23) Cray, M. C., Small, D. M., and Bliss, C. M., Lipid digestion and absorption. Annu. Rev. Physiol., 45, 651–677 (1983).
  • 24) Armand, M., Pasquier, B., Andre, M., Borel, P., Senft, M., Peyrot, J., Salducci, J., Portugal, H., Jaussan, V., and Lairon, D., Digestion and absorption of 2 fat emulsions with different droplet sizes in the human digestive tract. Am. J. Clin. Nutr., 70, 1096–1106 (1999).
  • 25) Juhel, C., Armand, M., Pafumi, Y., Rosier, C., Vandermander, J., and Lairon, D., Green tea extract (AR25) inhibits lipolysis of tryglycerides in gastric and duodenal medium in vitro. J. Nutr. Biochem., 11, 45–51 (2000).
  • 26) Raederstorff, D. G., Schlachter, M. F., Elste, V., and Weber, P., Effect of EGCG on lipid absorption and plasma lipid levels in rats. J. Nutr. Biochem., 14, 326–332 (2003).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.